Dietary treatment in adults with refractory epilepsy
A review
Abstract
We review adjunctive ketogenic diet (KD) and modified Atkins diet (MAD) treatment of refractory epilepsy in adults. Only a few studies have been published, all open-label. Because of the disparate, uncontrolled nature of the studies, we analyzed all studies individually, without a meta-analysis. Across all studies, 32% of KD-treated and 29% of MAD-treated patients achieved ≥50% seizure reduction, including 9% and 5%, respectively, of patients with >90% seizure frequency reduction. The effect persists long term, but, unlike in children, may not outlast treatment. The 3:1 and 4:1 [fat]:[carbohydrate + protein] ratio KD variants and MAD are similarly effective. The anticonvulsant effect occurs quickly with both diets, within days to weeks. Side effects of both diets are benign and similar. The most serious, hyperlipidemia, reverses with treatment discontinuation. The most common, weight loss, may be advantageous in patients with obesity. Potential barriers to large-scale use of both diets in adults include low rate of diet acceptance and high rates of diet discontinuation. The eligible screened/enrolled subject ratios ranged from 2.9 to 7.2. Fifty-one percent of KD-treated and 42% of MAD-treated patients stopped the diet before study completion. Refusal to participate was due to diet restrictiveness and complexity, which may be greater for KD than MAD. However, long-term adherence is low for both diets. Most patients eventually stop the diet because of culinary and social restrictions. For treatment of refractory status epilepticus, only 14 adult cases of KD treatment have been published, providing insufficient data to allow evaluation. In summary, KD and MAD treatment show modest efficacy, although in some patients the effect is remarkable. The diets are well-tolerated, but often discontinued because of their restrictiveness. In patients willing to try dietary treatment, the effect is seen quickly, giving patients the option whether to continue the treatment.
Get full access to this article
View all available purchase options and get full access to this article.
REFERENCES
1.
Brodie MJ, Barry SJ, Bamagous GA, Norrie JD, Kwan P. Patterns of treatment response in newly diagnosed epilepsy. Neurology 2012;78:1548–1554.
2.
Neal EG, Chaffe HM, Edwards N, et al. The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial. Lancet Neurol 2008;7:500–506.
3.
Sharma S, Sankhyan N, Gulati S, Agarwala A. Use of the modified Atkins diet for treatment of refractory childhood epilepsy: a randomized controlled trial. Epilepsia 2013;54:481–486.
4.
Hartman AL, Vining EP. Clinical aspects of the ketogenic diet. Epilepsia 2007;48:31–42.
5.
Kossoff EH, Zupec-Kania BA, Amark PE, et al. Optimal clinical management of children receiving the ketogenic diet: recommendations of the International Ketogenic Diet Study Group. Epilepsia 2009;50:304–317.
6.
Freeman JM, Vining EP, Pillas DJ, Pyzik PL, Casey JC, Kelly LM. The efficacy of the ketogenic diet-1998: a prospective evaluation of intervention in 150 children. Pediatrics 1998;102:1358–1363.
7.
Lefevre F, Aronson N. Ketogenic diet for the treatment of refractory epilepsy in children: a systematic review of efficacy. Pediatrics 2000;105:E46.
8.
Keene DL. A systematic review of the use of the ketogenic diet in childhood epilepsy. Pediatr Neurol 2006;35:1–5.
9.
Hartman AL, Gasior M, Vining EP, Rogawski MA. The neuropharmacology of the ketogenic diet. Pediatr Neurol 2007;36:281–292.
10.
Hemingway C, Freeman JM, Pillas DJ, Pyzik PL. The ketogenic diet: a 3- to 6-year follow-up of 150 children enrolled prospectively. Pediatrics 2001;108:898–905.
11.
Gazzola DM, Balcer LJ, French JA. Seizure-free outcome in randomized add-on trials of the new antiepileptic drugs. Epilepsia 2007;48:1303–1307.
12.
Vining EP. Long-term health consequences of epilepsy diet treatments. Epilepsia 2008;49(suppl 8):27–29.
13.
Kang HC, Chung DE, Kim DW, Kim HD. Early- and late-onset complications of the ketogenic diet for intractable epilepsy. Epilepsia 2004;45:1116–1123.
14.
Kwiterovich PO, Vining EP, Pyzik P, Skolasky R, Freeman JM. Effect of a high-fat ketogenic diet on plasma levels of lipids, lipoproteins, and apolipoproteins in children. JAMA 2003;290:912–920.
15.
Masino SA, Rho JM. In:, Noebels JL, Avoli M, Rogawski MA, Olsen RW, Delgado-Escueta AV, eds. Jasper's Basic Mechanisms of the Epilepsies, 4th ed. Bethesda, MD: National Center for Biotechnology Information (US); 2012.
16.
Masino SA, Li T, Theofilas P, et al. A ketogenic diet suppresses seizures in mice through adenosine A1 receptors. J Clin Invest 2011;121:2679–2683.
17.
Ma W, Berg J, Yellen G. Ketogenic diet metabolites reduce firing in central neurons by opening KATP channels. J Neurosci 2007;27:3618–3643.
18.
Juge N, Gray JA, Omote H, et al. Metabolic control of vesicular glutamate transport and release. Neuron 2010;68:99–112.
19.
Wheless JW. History of the ketogenic diet. Epilepsia 2008;49(suppl 8):3–5.
20.
Barborka C. Epilepsy in adults: results of treatment by ketogenic diet in one hundred cases. Arch Neurol 1930; 6:904–914.
21.
Sirven J, Whedon B, Caplan D, et al. The ketogenic diet for intractable epilepsy in adults: preliminary results. Epilepsia 1999;40:1721–1726.
22.
Nei M, Ngo L, Sirven J, Sperling MR. Ketogenic diet in adolescents and adults with epilepsy. Seizure 2014;23:439–442.
23.
Mosek A, Natour H, Neufeld MY, Shiff Y, Vaisman N. Ketogenic diet treatment in adults with refractory epilepsy: a prospective pilot study. Seizure 2009;18:30–33.
24.
Klein P, Janousek J, Barber A, Weissberger R. Ketogenic diet treatment in adults with refractory epilepsy. Epilepsy Behav 2010;19:575–579.
25.
Lambrechts DA, Wielders LH, Aldenkamp AP, Kessels FG, de Kinderen RJ, Majoie MJ. The ketogenic diet as a treatment option in adults with chronic refractory epilepsy: efficacy and tolerability in clinical practice. Epilepsy Behav 2012;23:310–314.
26.
Atkins RC. Dr. Atkins' New Diet Revolution. New York: Harper Collins; 2002.
27.
Kossoff EH, McGrogan JR, Bluml RM, Pillas DJ, Rubenstein JE, Vining EP. A modified Atkins diet is effective for the treatment of intractable pediatric epilepsy. Epilepsia 2006;47:421–424.
28.
Kossoff EH, Rowley H, Sinha SR, Vining EPG. A prospective study of the modified Atkins diet for intractable epilepsy in adults. Epilepsia 2008;49:316–319.
29.
Carrette E, Vonck K, de Herdt V, et al. A pilot trial with modified Atkins' diet in adult patients with refractory epilepsy. Clin Neurol Neurosurg 2008;110:797–803.
30.
Smith M, Politzer N, Macgarvie D, McAndrews MP, Del Campo M. Efficacy and tolerability of the modified Atkins diet in adults with pharmacoresistant epilepsy: a prospective observational study. Epilepsia 2011;52:775–780.
31.
Cervenka MC, Terao NN, Bosarge JL, et al. E-mail management of the modified Atkins diet for adults with epilepsy is feasible and effective. Epilepsia 2012;53:728–732.
32.
Kossoff EH, Henry BJ, Cervenka MC. Efficacy of dietary therapy for juvenile myoclonic epilepsy. Epilepsy Behav 2013;26:162–164.
33.
Kossoff EH, Nabbout R. Use of dietary therapy for status epilepticus. J Child Neurol 2013;28:1049–1051.
34.
Bodenant M, Moreau C, Sejourne C, et al. Interest of the ketogenic diet in a refractory status epilepticus in adults [in French]. Rev Neurol 2008;164:194–199.
35.
Wusthoff CJ, Kranick SM, Morley JF, Christina Bergqvist AG. The ketogenic diet in treatment of two adults with prolonged nonconvulsive status epilepticus. Epilepsia 2010;51:1083–1085.
36.
Nam SH, Lee BL, Lee CG, et al. The role of ketogenic diet in the treatment of refractory status epilepticus. Epilepsia 2011;52:e181–e184.
37.
Cervenka MC, Hartman AL, Venkatesan A, Geocadin RG, Kossoff EH. The ketogenic diet for medically and surgically refractory status epilepticus in the neurocritical care unit. Neurocrit Care 2011;15:519–524.
38.
Thakur KT, Probasco JC, Hocker SE, et al. Ketogenic diet for adults in super-refractory status epilepticus. Neurology 2014;82:665–670.
39.
Baumeister FA, Oberhoffer R, Liebhaber GM, et al. Fatal propofol infusion syndrome in association with ketogenic diet. Neuropediatrics 2004;35:250–252.
40.
Payne NE, Cross JH, Sander JW, Sisodiya SM. The ketogenic and related diets in adolescents and adults: a review. Epilepsia 2011;52:1941–1948.
41.
Gruenthal M. Comment: should we induce ketosis in super-refractory status epilepticus? Neurology 2014;82:669.
Information & Authors
Information
Published In
Copyright
© 2014 American Academy of Neurology.
Publication History
Received: March 12, 2014
Accepted: August 20, 2014
Published online: October 29, 2014
Published in print: November 18, 2014
Disclosure
P. Klein is on UCB Pharma, GlaxoSmithKline, and Eisai speakers' bureaus, has served on Advisory Boards of Acorda, Eisai, and Sunovion, and has participated in clinical trials sponsored by UCB Pharma, Eisai, GlaxoSmithKline, Sunovion, Lundbeck, and SK Life Sciences. I. Tyrlikova reports no disclosures relevant to the manuscript. G. Mathews has participated in clinical trials sponsored by UCB Pharma, Eisai, GlaxoSmithKline, Lundbeck, and SK Life Sciences. Go to Neurology.org for full disclosures.
Study Funding
No targeted funding reported.
Authors
Author Contributions
Pavel Klein: contributed to the writing of the manuscript. Ivana Tyrlikova: contributed to the writing of the manuscript. Gregory Mathews: contributed to the writing of the manuscript.
Metrics & Citations
Metrics
Citations
Download Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
Cited By
- Keto Is Not Just for Kids: A Randomized Trial of a Modified Atkins Diet for Adolescents and Adults With Anti-Seizure Medication-Resistant Epilepsy, Epilepsy Currents, 23, 3, (147-149), (2023).https://doi.org/10.1177/15357597231157488
- Modifizierte Atkins Diät bei therapierefraktärer Epilepsie, Fortschritte der Neurologie · Psychiatrie, 91, 07/08, (279-279), (2023).https://doi.org/10.1055/a-2080-1365
- Difficulties in the implementation of the ketogenic diet in adult patients with refractory epilepsy, Epilepsy & Behavior, 144, (109234), (2023).https://doi.org/10.1016/j.yebeh.2023.109234
- Prospective study of the modified Atkins diet in adult drug-resistant epilepsy: effectiveness, tolerability, and adherence, Neurología (English Edition), (2023).https://doi.org/10.1016/j.nrleng.2021.10.008
- Brain trauma, ketogenic diets, and ketogenesis via enteral nutrition, Diet and Nutrition in Neurological Disorders, (257-280), (2023).https://doi.org/10.1016/B978-0-323-89834-8.00006-4
- Neurology, Ketogenic, (237-306), (2023).https://doi.org/10.1016/B978-0-12-821617-0.00006-1
- Exercise and Nutritional Guidelines for Weight Loss and Weight Maintenance in the Obese Female, The Active Female, (579-598), (2023).https://doi.org/10.1007/978-3-031-15485-0_32
- The Role of Ketogenic Diet in the Treatment of Neurological Diseases, Nutrients, 14, 23, (5003), (2022).https://doi.org/10.3390/nu14235003
- Influence of Aging, Macronutrient Composition and Time-Restricted Feeding on the Fischer344 x Brown Norway Rat Gut Microbiota, Nutrients, 14, 9, (1758), (2022).https://doi.org/10.3390/nu14091758
- Fats, Friends or Foes: Investigating the Role of Short- and Medium-Chain Fatty Acids in Alzheimer’s Disease, Biomedicines, 10, 11, (2778), (2022).https://doi.org/10.3390/biomedicines10112778
- See more
Loading...
View Options
Get Access
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
Purchase this article to get full access to it.